Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Esma S. Yolcu"'
Autor:
Martin R. Ramos-Gonzalez, Nagabhishek Sirpu Natesh, Satyanarayana Rachagani, James Amos-Landgraf, Haval Shirwan, Esma S. Yolcu, Jorge G. Gomez-Gutierrez
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 19, p 10418 (2024)
Luciferase (luc) bioluminescence (BL) is the most used light-emitting protein that has been engineered to be expressed in multiple cancer cell lines, allowing for the detection of tumor nodules in vivo as it can penetrate most tissues. The goal of th
Externí odkaz:
https://doaj.org/article/cf6403a35bd0411897e152d690112bb7
Publikováno v:
STAR Protocols, Vol 5, Iss 1, Pp 102816- (2024)
Summary: Although the male epididymal fat pad is an effective site for islet transplantation, females lack this tissue. Here, we present a protocol to assess the parametrial fat pad (PFP) adjacent to the uterine horn in females as an alternative site
Externí odkaz:
https://doaj.org/article/ff71f8f3228141d7bbe73edf05f49dc2
Autor:
Martin R. Ramos-Gonzalez, Mohammad Tarique, Lalit Batra, Feyza Arguc, Rodolfo Garza-Morales, Haval Shirwan, Esma S. Yolcu, Jorge G. Gomez-Gutierrez
Publikováno v:
Vaccines, Vol 12, Iss 3, p 340 (2024)
Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8+ T cells. We reported the generation of an active soluble oligomeric construct, SA-4-1BBL, with demonstrated immunoprevention a
Externí odkaz:
https://doaj.org/article/4f3b2ac5951748d89193695c80997c63
Publikováno v:
STAR Protocols, Vol 3, Iss 2, Pp 101416- (2022)
Summary: Murine intrahepatic islet transplantation is a clinically relevant but technically challenging surgical procedure because of frequent lethal postoperative bleeding. Here, we describe a protocol for mouse pancreatic islet isolation, purificat
Externí odkaz:
https://doaj.org/article/b4df51075b3e4edeb6378038bc117a15
Autor:
Shravan Madireddi, Rich-Henry Schabowsky, Abhishek K. Srivastava, Rajesh K. Sharma, Esma S. Yolcu, Haval Shirwan
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/cf6e3a759b8741649e2cb91c16cb23b1
Autor:
Pradeep Shrestha, Ali Turan, Lalit Batra, Ayse Ece Gulen, Zhengda Sun, Helen Tan, Nadir Askenasy, Haval Shirwan, Esma S. Yolcu
Publikováno v:
Blood Advances. 7:2181-2195
Alloreactive T-effector cells (Teffs) are the major culprit of acute graft-versus-host disease (aGVHD) associated with hematopoietic stem cell transplantation. Ex vivo nonspecific depletion of T cells from the donor graft impedes stem cell engraftmen
Autor:
Ali Turan, Lei Zhang, Mohammad Tarique, Vahap Ulker, Feyza Nur Arguc, Darshan Badal, Esma S. Yolcu, Haval Shirwan
Publikováno v:
American Journal of Transplantation. 23:619-628
Autor:
Juan D, Medina, Graham F, Barber, Maria M, Coronel, Michael D, Hunckler, Stephen W, Linderman, Michelle J, Quizon, Vahap, Ulker, Esma S, Yolcu, Haval, Shirwan, Andrés J, García
Publikováno v:
Journal of Biomedical Materials Research Part A. 110:1728-1737
Type 1 diabetes (T1D), an autoimmune disorder in which the insulin-producing β-cells in the islets of Langerhans in the pancreas are destroyed, afflicts over 1.6 million Americans. Although pancreatic islet transplantation has shown promise in treat
Autor:
Haval Shirwan, Esma S. Yolcu, Kathryn J. MacLeod, Robert W. Miller, Zhenping Zhong, Hong Zhao, Shravan Madireddi, Kutlu G. Elpek, Abhishek K. Srivastava, Rich-Henry Schabowsky, Rajesh K. Sharma
Supplementary Figures 1-5, Methods from 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d862589cdd94ed5132c29996098a81d
https://doi.org/10.1158/0008-5472.22381974.v1
https://doi.org/10.1158/0008-5472.22381974.v1
Autor:
Haval Shirwan, Esma S. Yolcu, Kathryn J. MacLeod, Robert W. Miller, Zhenping Zhong, Hong Zhao, Shravan Madireddi, Kutlu G. Elpek, Abhishek K. Srivastava, Rich-Henry Schabowsky, Rajesh K. Sharma
Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer. However, poor immunogenicity of TAAs requires potent adjuvants for therapeutic efficacy. We recently proposed the tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e901b4db577ef7712b6cd2fb033b0f8
https://doi.org/10.1158/0008-5472.c.6500049.v1
https://doi.org/10.1158/0008-5472.c.6500049.v1